182 related articles for article (PubMed ID: 35451226)
1. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
2. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
3. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
5. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
6. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
[TBL] [Abstract][Full Text] [Related]
7. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
8. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP
JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268
[TBL] [Abstract][Full Text] [Related]
10. Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Ishida Y; Qiu D; Maeda M; Fujimoto J; Kigasawa H; Kobayashi R; Sato M; Okamura J; Yoshinaga S; Rikiishi T; Shichino H; Kiyotani C; Kudo K; Asami K; Hori H; Kawaguchi H; Inada H; Adachi S; Manabe A; Kuroda T
Int J Clin Oncol; 2016 Jun; 21(3):506-16. PubMed ID: 26620038
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
12. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
13. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
[TBL] [Abstract][Full Text] [Related]
14. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
[TBL] [Abstract][Full Text] [Related]
15. Cause-specific mortality in long-term survivors of retinoblastoma.
Yu CL; Tucker MA; Abramson DH; Furukawa K; Seddon JM; Stovall M; Fraumeni JF; Kleinerman RA
J Natl Cancer Inst; 2009 Apr; 101(8):581-91. PubMed ID: 19351917
[TBL] [Abstract][Full Text] [Related]
16. Benign Tumors in Long-Term Survivors of Retinoblastoma.
van Hoefen Wijsard M; Schonfeld SJ; van Leeuwen FE; Moll AC; Fabius AW; Abramson DH; Seddon JM; Francis JH; Tucker MA; Kleinerman RA; Morton LM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917779
[TBL] [Abstract][Full Text] [Related]
17. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
18. Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors.
Lim H; Im M; Seo ES; Cho HW; Ju HY; Yoo KH; Cho SY; Kim JW; Lim DH; Sung KW; Lee JW
Cancer Res Treat; 2024 Apr; 56(2):642-651. PubMed ID: 37997325
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
[TBL] [Abstract][Full Text] [Related]
20. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
